SUMAN THOMAS: Open Payments
NPI 1720498678 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 13 payments from 8 companies in 2025. Trend: 2023 $175 · 2024 $209 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $173 |
| Janssen Pharmaceuticals, Inc | 3 | $47 |
| Lilly USA, LLC | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Alkermes, Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: SYMPLICITY G3, INVEGA SUSTENNA, KISUNLA, LYBALVI, JARDIANCE, LEQVIO, VRAYLAR, ABILIFY ASIMTUFII.
Industry payments across NJ — which companies pay providers there.
